MeVis Medical Solutions AG raised its forecast for the fiscal year 2015 due to the sale of treasury shares. For the year 2015 revenues are expected to remain stable at between EUR 13.0 million and EUR 13.5 million (as in the previous forecast). For the EBIT (earnings before interest and taxes), a decrease over the previous year to EUR 2.0 million to EUR 2.5 million continues to be expected (as in the previous forecast).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.6 EUR | -3.03% | -3.76% | +1.59% |
1st Jan change | Capi. | |
---|---|---|
+1.59% | 5.15Cr | |
-5.02% | 2.94TCr | |
+42.01% | 941.78Cr | |
+33.25% | 437.93Cr | |
-41.72% | 211.12Cr | |
-7.91% | 160.39Cr | |
-30.48% | 122.39Cr | |
-42.86% | 100.54Cr | |
+4.72% | 92Cr | |
-46.87% | 73Cr |
- Stock Market
- Equities
- M3V Stock
- News MeVis Medical Solutions AG
- MeVis Medical Solutions AG Revises Guidance for the Fiscal Year 2015